1. 139 A retrospective review of lung cancer patients receiving whole brain radiotherapy treated at the Kent Oncology Centre (KOC) in 2014, audited against the QUARTZ trial. (January 2016) Authors: Hegarty, G.; Turner, J.Y.; Sevitt, T.; Burcombe, R.; Cominos, M.; Taylor, H.; Beesley, S.; Hadaki, M.; Shah, R.; Mikropoulos, C.; Hall, J. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 64 Management of EGFR tyrosine kinase inhibitor associated skin toxicity: a single centre experience. (January 2016) Authors: Thomas, L.; Hadaki, M.; Sevitt, T.; Shah, R.; Burcombe, R.; Hall, J.; Taylor, H.; Beesley, S.; Cominos, M. Journal: Lung cancer Issue: Volume 91(2016)Supplement 1 Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 66: Adjuvant chemotherapy dose delivery for completely resected NSCLC in a regional cancer centre: analysis of outcomes by age and comorbidity. (January 2015) Authors: Wood, S.; Li, R.; Beesley, S.; Brown, J.; Cominos, M.; Hall, J.; Sevitt, T.; Shah, R.; Taylor, H.; Burcombe, R. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 71: Audit of the epidermal growth factor tyrosine kinase (EGFR) and anaplastic lymphoma kinase (ALK) mutation request pathway in non-squamous non-small cell lung cancer (NSCLC) in Kent. (January 2015) Authors: Taylor, H.; Shah, R.; Mccormick, G.; Burcombe, R.; Beesley, S.; Cominos, M.; Hall, J.; Sevitt, T. Journal: Lung cancer Issue: Volume 87(2015)Supplement 1 Page Start: S28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Audit of stage III non-small cell lung cancer (NSCLC) management at Maidstone and Tunbridge Wells NHS Trust (MTW). (January 2020) Authors: Sevitt, T.; Young, T.; Burcombe, R. Journal: Lung cancer Issue: Volume 139(2020)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Decision-making for Adjuvant Chemotherapy in the Absence of Genomic Testing for Breast Cancer Patients with 'Intermediate' Risk of Mortality at 10 Years. Issue 5 (May 2016) Authors: Alrifai, D.; Harper-Wynne, C.; Jyothirmayi, R.; Burcombe, R. Journal: Clinical oncology Issue: Volume 28:Issue 5(2016) Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Enhanced axillary assessment using contrast enhanced ultrasound (CEUS) before neo-adjuvant systemic therapy (NACT) in breast cancer patients identifies axillary disease missed by conventional B-mode ultrasound that may be clinically relevant. (October 2020) Authors: Cox, K.; Dineen, N.; Weeks, J.; Allen, D.; Akolekar, D.; Chalmers, R.; Burcombe, R.; Harper-Wynne, C.; Jyothirmayi, R.; Abson, C. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Eribulin Use and Palliative Care Referral Rates in Metastatic Breast Cancer: Kent Oncology Centre Experience. Issue 8 (August 2020) Authors: Little, J.; Burcombe, R.; Parsons, E.; Ryan, C. Journal: Clinical oncology Issue: Volume 32:Issue 8(2020) Page Start: e171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. First-line Treatment Modality for Metastatic Breast Cancer: A Single Institution Outcome Analysis by Metastatic Site and Molecular Subtype. Issue 6 (June 2018) Authors: Sim, V.; Flynn, M.; Hegarty, G.; Ryan, C.; Parsons, E.; Abson, C.; Harper-Wynne, C.; Jyothirmayi, R.; Webb, J.; Burcombe, R. Journal: Clinical oncology Issue: Volume 30:Issue 6(2018) Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PO-0882: Single centre review of the survival benefit and toxicity of PCI in Small Cell Lung Cancer. (November 2020) Authors: Forner, S.; Vasiliadou, I.; Little, J.; Fenton, M.; Goyal, S.; Burcombe, R.; Brulinski, P.; Sevitt, T. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗